📰 Interim Head News
Page 23 - Interim Head News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Interim Head. Real-time updates on events, politics, business and more.
December 14, 2022
Former Head of State of Guinea, Captain Moussa Dadis Camara, took the stand on Monday, December 12, 2022 to respond to allegations brought against him and several of his compatriots (mostly military men), who are accused of orchestrating the massacre
December 12, 2022
Health officials are urging people to take up the offer of a flu jab amid warnings that Wales could see “high levels” of the virus by Christmas. The flu season has started earlier than usual this year, with a rise in cases being reported in the community and also in patients attending hospital. Public health […]
December 11, 2022
The Western Health and Social Care Trust (Western Trust) are celebrating the success of our Allied Health Professionals in the annual Advancing Healthcare Award...
December 8, 2022
Mississippi Valley State head coach resigned to follow Deion Sanders to join his staff in Colorado.
December 6, 2022
Over one million people in Wales have received a COVID-19 booster vaccination this autumn. Public Health Wales’s weekly data, published today, shows the number of people who have now received their booster reached 1,023,594 last week. It has also been confirmed that all eligible people in Wales should by now have received an invitation for […]
December 6, 2022
06.12.2022 - Sage Therapeutics, Inc. (Nasdaq: SAGE) and Biogen Inc. (Nasdaq: BIIB) announced the completion of the rolling submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for zuranolone in the treatment of major ... Seite 1
December 6, 2022
The EMA has accepted the marketing authorisation application for tofersen, which could be the first treatment for a rare genetic cause of ALS.
December 5, 2022
Animal Abusers win thru censorship in a free-speech North Carolina student newspaper. The almighty dollar is more powerful than University policy.
December 5, 2022
SOD1-ALS is a rare, genetic form of ALS,1 comprising approximately 2% of people with ALS2If approved, tofersen would be the first treatment to target a genetic cause of ALS CAMBRIDGE, Mass., Dec. ... | December 5, 2022
December 5, 2022
WESTON (dpa-AFX) - Biogen Inc. (BIIB) announced Monday that the European Medicines Agency or EMA has accepted the Marketing Authorization Application or MAA for review of tofersen to treat rare